Tag: ReShape Lifesciences
Neuromodulation – the future of diabetes treatments

The treatments for type 2 diabetes are limited in breadth and effectiveness. Medications have side effects, and many patients forget to take their medications regularly. An alternative treatment option that does not require daily compliance could provide better outcomes and is more likely to be used by patients. Dr Jonathan Waataja of ReShape Lifesciences in California, USA and colleagues have […]
Read More… from Neuromodulation – the future of diabetes treatments